期刊文献+

建立和完善“精准医疗”相关政策,促进体外诊断试剂产业创新与升级 被引量:2

Establishing and Improving Related Policies for "Precision Medicine" to Promote the Innovation and Upgrade of in vitro Diagnostic Reagent Industry
下载PDF
导出
摘要 目的:聚焦'精准医疗',探讨'精准医疗'工作中体外诊断试剂产业发展需求,以期促进我国'精准医疗'涉及的高端诊断医疗产品发展。方法:从我国'精准医疗'涉及的体外诊断试剂产业现状、创新体系以及相关技术等方面,分析体外诊断试剂产业发展面临的问题并提出相关建议,为发展'精准医疗'涉及的高端诊断试剂产业提供参考。结果与结论:随着我国'精准医疗'工作的开展,为高端诊断产品发展带来了机遇,同时也面临诸多挑战,如研发投入严重不足,创新体系配套政策欠缺,国家及行业标准制修订滞后等问题。应从加速配套政策建立、加强体外诊断试剂标准、质量管理体系建设等方面着手,提升我国'精准医疗'核心竞争力,推动诊断产品创新体系建设,促进体外诊断试剂产业发展。 Objective:To promote the development of high-end diagnostic medical products involved in'precision medicine'in China by focusing on'precision medicine'and exploring the development need of in vitro diagnostic reagent industry in'precision medicine'.Methods:The problems faced by in vitro diagnostic reagent industry development were analyzed from the status quo,innovation system and related technology of in vitro diagnostic reagent industry involved in'precision medicine'in China,and made relevant suggestions so as to provide references for the development of high-end diagnostic reagent industry involved in'Precision medicine'.Results and Conclusion:The development of'Precision medicine'in China has brought opportunities for the development of high-end diagnostic products but at the same time it has brought many challenges,such as serious shortage of investment in research and development,lack of supporting policies for innovation systems,as well as lags in the revision of national and industry standards.It is suggested that the establishment of supporting policies should be set up and the construction of in vitro diagnostic reagent standards and quality management systems should be strengthened to improve the core competitiveness of'precision medicine'and promote the construction of innovation system of diagnostic products and the development of in vitro diagnostic reagent industry of China.
作者 李颖 杨振 姚蕾 李丽莉 孙彬裕 张孝明 Li Ying;Yang Zhen;Yao Lei;Li Lili;Sun Binyu;Zhang Xiaoming(National Institutes for Food and Drug Control,Beijing 100050,China)
出处 《中国药事》 CAS 2019年第9期1046-1050,共5页 Chinese Pharmaceutical Affairs
关键词 精准医疗 体外诊断试剂 创新体系 precision medicine in vitro diagnostic reagent innovation system
  • 相关文献

参考文献12

二级参考文献101

  • 1程妍,刘仲林.计算生物学——一门充满活力的新兴交叉学科[J].科学学与科学技术管理,2006,27(3):11-15. 被引量:11
  • 2The white house, office of the press secretary. Fact sheet:president obama's precision medicine initiative [OL]. (2015-01-30) [2015-03-20]. https://www.whitehouse.gov/ the-press-office/2015/01/30/fact-sheet-president-obama-s- precision-medicine-initiative.
  • 3Collins F S, Varmus H. A new initiative on precision medicine [J]. NEnglJMed, 2015, 372(9): 793-795.
  • 4Wikipedia, the free encyclopedia. Precision medicine lOLl. (2015-03-07) [2015-03-20]. http://en.wikipedia.org/ wiki/Precision medicine.
  • 5NIH. What are the near-term goals? Expanding efforts in cancer [OL]. (2015-02-09) [2015-03-20]. http://www.nih. gov/precisionmedicine/goals.htm.
  • 6Mimezami R, Nicholson J, Darzi A. Preparing for precision medicine [J]. N Engl J Med, 2012, 366(6): 489-491.
  • 7Suzanne L. Topalian,F. Stephen Hodi,Julie R. Brahmer.Safety, Activity, and Immune Correlates of Anti-PD-1 Antibody in Cancer. New England Journal of Homeopathy . 2012
  • 8Tetsuya Mitsudomi,Satoshi Morita,Yasushi Yatabe,Shunichi Negoro,Isamu Okamoto,Junji Tsurutani,Takashi Seto,Miyako Satouchi,Hirohito Tada,Tomonori Hirashima,Kazuhiro Asami,Nobuyuki Katakami,Minoru Takada,Hiroshige Yoshioka,Kazuhiko Shibata,Shinzoh Kudoh,Eiji Shimizu,Hiroshi Saito,Shinichi Toyooka,Kazuhiko Nakagawa,Masahiro Fukuoka.Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, randomised phase 3 trial[J]. Lancet Oncology . 2010 (2)
  • 9CHEN R, SNYDER M. Promise of personalized omics to precision medicine[J]. Wiley Interdisciplinary Reviews: Systems Biology and Medicine, 2013, 5(1): 73-82.
  • 10MIRNEZAMI R, NICHOLSON J, DARZI A. Preparing for precision medi- cine[J]. New England Journal of Medicine, 2012, 366(6): 489-491.

共引文献204

同被引文献18

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部